https://www.selleckchem.com/products/sp2509.html
79, 95% CI 0.45-1.40, P=0.43, respectively). Duration of OC use was not related to increased risks of HF. When stratifying HF into subtypes, similar associations were observed. In multivariable-adjusted regression models, OC use was positively associated with left ventricular end-diastolic mass [coefficient (β)=3.04, P=0.006] and stroke volume (β=1.76, P=0.01 for the left ventricle; β=2.17, P=0.005 for the right ventricle) but had no impact on left ventricular ejection fraction (β=0.09, P=0.75) and right ventricular ejection fraction (β=